Skip to content

DMT: all studies

Page 150 of 160: studies 1,491 to 1,500 of 1,593, newest first. Back to the DMT overview

Research

Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus.

Pharmacology, Biochemistry, and Behavior July 1988 Jerrold C Winter, R A Rabin

Drugs purported to have selective affinities for 5-HT1A, 5-HT1B, and 5-HT2 receptors were tested in rats trained with 0.1 mg LSD versus saline. Included were 5-methoxy-dimethyltryptamine (MDMT), 2,5-dimethoxy-4-methyl-amphetamine (DOM), 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), m-trifluoromethylphenyl-piperazine (TFMPP), and 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole...

Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.

European Journal of Pharmacology 1988 R A Lyon, M Titeler, M R Seggel et al.

Twenty-one indolealkylamines, some of which are known to be psychoactive in man, were examined for their binding interactions with rat brain cortical 5-HT2 receptors labeled with the antagonist radioligand [3H]ketanserin in order to develop structure-activity relationships for binding at these sites. Features investigated included aromatic, alpha-methyl and terminal amine substituents....

DOI: 10.1016/0014-2999(88)90432-3 (opens in new tab) Cerebral cortex Animals Rats, inbred strains Amines +11

Site-selective serotonin agonists as discriminative stimuli.

Psychopharmacology series 1988 Richard A Glennon

Various direct- and indirect-acting serotonin (5-HT) agonists serve as training drugs in tests of stimulus control of behavior; such agents include: 5-hydroxytryptophan, 5-methoxy-N,N-dimethyltryptamine, and fenfluramine. However, with the recent discovery of multiple populations of central 5-HT binding sites, the concept of site-selective serotonergic agents needs to be addressed. Certain...

Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.

Journal of Pharmacology and Experimental Therapeutics December 1, 1987 Toshitaka Nabeshima, K Yamaguchi, K Ishikawa et al.

Phencyclidine (PCP)-induced behaviors were compared with 5-methoxy-N,N-dimethyltryptamine (5-MeODMT)- and p-chloroamphetamine-induced behaviors in rats pretreated with ritanserin or 5,7-dihydroxytryptamine (5,7-DHT) in order to investigate whether PCP interacts with 5-hydroxytryptamine2 (5-HT2) receptors. Head-twitch and wet-dog shake induced by p-chloroamphetamine, a 5-HT releaser, and...

DOI: 10.1016/s0022-3565(25)39280-3 (opens in new tab) Animals Rats, inbred strains Biogenic amines Methoxydimethyltryptamines +14

The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory.

Pharmacology, Biochemistry, and Behavior August 1, 1987 Jerrold C Winter, D T Petti 128 citations

A group of ten rats was trained to obtain food pellets in an 8-arm radial maze. The effects of pretreatment with (+)-Lysergic acid diethylamide (+)-tartrate (LSD), m-trifluoromethylphenylpiperazine (TFMPP), 5-methoxy-N,N-dimethyltryptamine oxalate (5-MeO-DMT), racemic 8-hydroxy-2-(di-n-propylamino)tetralin HBr (8-OH-DPAT), and 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole succinate (RU...

Phencyclidine-induced head-weaving observed in mice after ritanserin treatment.

European Journal of Pharmacology July 9, 1987 Toshitaka Nabeshima, K Ishikawa, K Yamaguchi et al. 17 citations

Ritanserin (0.125, 0.25, 0.5, 1.0 and 2.0 mg/kg s.c.), a selective serotonin (5-HT2) receptor antagonist, produced a dose-dependent inhibition of the head-twitch response induced in mice by phencyclidine (PCP) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT). In contrast, ritanserin, dose dependently increased PCP- and 5-MeODMT-induced head-weaving. There was a significant inverse relationship...

Phencyclidine-induced head-twitch responses as 5-HT2 receptor-mediated behavior in rats.

Neuroscience Letters May 19, 1987 Toshitaka Nabeshima, K Ishikawa, K Yamaguchi et al. 27 citations

This study was designed to assess whether phencyclidine (PCP)-induced head-twitch was antagonized by ritanserin, a selective serotonin (5-HT2) receptor antagonist, in mice and rats to confirm the involvement of 5-hydroxytryptamine (5-HT) neurons in PCP actions in comparison with 5-methoxy-N,N-dimethyltryptamine (5-MeODMT)-induced behavior. PCP (7.5, 10 and 12.5 mg/kg, i.p.)-induced head-twitch...

Study of metabolism of psychotomimetic indolealkylamines by rat tissue extracts using liquid chromatography.

Biochemical Pharmacology May 1, 1987 B R Sitaram, R Talomsin, G L Blackman et al. 23 citations

The use of a series of liquid chromatographic techniques involving cation-exchange, reverse-phase and normal-phase chromatography has permitted the separation and characterisation of a number of metabolites of the psychotomimetic indolealkylamines N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine which were isolated following incubation of these compounds with rat tissue extracts. In...

Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine.

European Journal of Pharmacology March 3, 1987 Toshitaka Nabeshima, H Fukaya, K Yamaguchi et al. 70 citations

In rats treated with phencyclidine (PCP) repeatedly (PCP 10 mg/kg per day for 14 days), the back-pedalling, head-weaving and turning induced by PCP were attenuated (tolerance), while PCP-induced sniffing, rearing and ambulation were potentiated (supersensitivity). The behavior induced by the direct and indirect serotonin (5-HT) agonists, 5-methoxy-N,N-dimethyltryptamine and p-chloroamphetamine,...

Phencyclidine-induced head-twitch response in rats treated chronically with methysergide.

European Journal of Pharmacology January 20, 1987 Toshitaka Nabeshima, K Ishikawa, K Yamaguchi et al. 27 citations

This study was designed to assess whether phencyclidine (PCP)-induced behaviors in rats were potentiated after two days' withdrawal from chronic methysergide (a 5-HT2 receptor blocker) treatment (10 mg/kg per day i.p. for 12 days), in order to confirm the involvement of 5-hydroxytryptamine (5-HT) neurons in PCP actions. The PCP (10 mg/kg)-induced behaviors (head-twitch, head-weaving, turning...